Nextcure Inc
Company Overview
NextCure is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases. The company's primary focus is on developing innovative cancer treatments through their proprietary FIND-IO™ platform technology.
Their lead product candidate is NC318, a monoclonal antibody targeting Siglec-15, which is being evaluated for the treatment of advanced or metastatic solid tumors. The company is also developing NC410, a fusion protein designed to block immune suppression mediated by LAIR-1.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Nextcure Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.